SlideShare une entreprise Scribd logo
1  sur  7
Lesson N4: LABORATORY DIAGNOSIS OF ESCHERICHIOSIS

1.Scientifically methodical ground of theme
 Strains of Escherichia coli and related Gram-negative bacteria predominate among the aerobic commensal flora
present in the gut of man and animals. Individuals have a rich flora in the lower ileum and, more specially, in the
colon, which includes Escherichia coli. It is acquired by ingestion of the organisms during the first few days after
birth. The species Escherichia coli contains a great variety of strains that include purely commensal organisms as
well as those possesing combinations of virulance determinants that enable them to act as spesific pathogens of the
gut and extraintestinal sites, especially the urinary tract.

2.Educational purpose
      Students must know:
      1. Structure, staining properties ànd cultivation E. coli.
      2. Antigenic structure of E. coli, their classification.
      3. Fermentative properties and toxin production of E. coli
      4. Main clinical forms of escherichiosis.
      5. Methods of laboratory diagnosis of diseases, main methods of prophylaxis and treatment.

      Students should be able to:
      – prepare the smears from pure culture;
      – stain the smears by Gram’s technique;
      – make microscopical examination of the smears;
      - carry out agglutination test for determination of serovar of E. coli.
      3.Chart of topic content.
         Escherichia coli. The organism was isolated from faeces in 1885 by T. Escherich.E.coli is a common
inhabitant of the large intestine of humans and mammals. It is also found in the guts of birds, reptiles, amphibians,
and insects. The bacteria are excreted in great numbers with the faeces and are always present in the external
environment (soil, water, foodstuffs, and other objects).
         Morphology. E coli are straight rods measuring 0.4-0.7 in breadth and 1-3 in length. They occur as
individual organisms or in pairs and are marked by polymorphism. There are motile and non-motile.The cell
surface has pili on which certain phages are adsorbed. The microcapsule is not always clearly defined.
       Cultivation. E. coli is a facultative anaerobe. The optimum temperature for growth is 30-37 °C and the
optimum pH value of medium up 7.2-7.5. The organism also grows readily on ordinary media at room temperature
and at 10 and 45 °C, growth becomes visible in the first two days. E. coli from cold-blooded animals grows at
22-37° C but not at 42-43° C.
       On meat-peptone agar E. coli produces slightly convex semitransparent, greyish colonies, and in meat broth
it forms diffuse turbidity and a precipitate. The organism produces colonies which are red on Ploskirev's medium,
red with a metallic hue on Endo's medium, and dark-blue on Levin's medium.
       Fermentative properties.Glucose, lactose, mannitol, maltose and many other sugers are fermented with
production of acid and gas. Tipical strains do not fermant sucrose. Gelatin is not liquified, H2S is not formed, irea is
not split and growth does not occur in KCN medium.
         Virulence factors. Certain strains of E. coli are conditionally pathogenic. They contain a gluco-lipo-protein
complex with which their toxic, antigenic, and immunogenic properties are associated. Some strains possess
haemolytic properties (O124 and others) determined by plasmids. Pathogenic cultures possess endotoxins and
thermolabile neurotropic exotoxins. The latter accumulate in broth cultures on the second-fourth day of cultivation,
while the endotoxins appear only after the twentieth day. Haemotoxins and pyrogenic substances, proteinases,
deoxyribonucleases, urease, phosphatase, hyaluronidase, amino acid decarboxylases have been obtained from
pathogenic strains.
       Antigenic structure. The antigenic structure of E. coli is characterized by variability and marked
individuality. Along with the H- and O-antigens, the presence of other antigens has been shown m some strains, i.e.
the surface somatic (membranous, capsular) K-antigens which contain the thermolabile L- and B-antigens and the
thermostable A- and M-antigens.
       Each antigen group in its turn is composed of a number of antigens designated by Arabic numbers, e.g. the
O-group has 173 antigens, the K-subgroup 90, the H-subgroup 50, etc. On the basis of antigenic structure an
antigenic formula is derived which fully reflects the antigenic properties of the strain.For example, one of the most

                                                                                                                      1
widely spread serotypes is designated 0111 : K58 : H2. Under the effect of transformation, lysogenic conversion,
transduction, and conjugation E. coli may change its antigenic properties.
       Numerous varieties of the organism are produced on cultivation under artificial conditions. Such varieties are
not only of theoretical interest, but also of great practical importance in laboratory diagnosis of enteric infections.
       Classification. The genus Escherichia includes E. coli, E. freundi, E. intermedia, and others. E. coli species
consisting of several biotypes and serotypes. They are differentiated according to cultural, biochemical, and
serological properties F. Kauffmann has detected 25 O-groups responsible for various diseases in humans.
       About 50 phage variants have been revealed among E. coli organisms. They are used in laboratory diagnosis
as confirmatory characteristics of the isolated serotypes.
       Resistance. E. coli survives in the external environment for months. It is more resistant to physical and
chemical factors of the external environment than the typhoid and dysentery bacteria. E. coli is killed
comparatively rapidly by all methods and preparations used for disinfection. At 55° C the organism perishes in 1
hour, and at 60° C in 15 minutes. E. coli is sensitive to brilliant green.
       E. coli is used as a test microbe in the assay of disinfectants and methods of disinfection and also in titration
of certain antibiotics.
       Pathogenesis and diseases in man. Definite E. coli serogroups are capable of causing various acute
intestinal diseases in humans: (1) the causative agents of colienteritis in children are O-groups-25, -26, -44, -55,
-86, -91, -111, -114, -119, -125, -126, -127, -128, -141, -146, and others (they cause diseases in infants of the first
months of life and in older infants); (2) the causative agents of dysentery-like diseases are E. coli of the O-
groups-23, -32, -115, -124, -136, -143, -144, -151, and others; (3) the causative agents of cholera-like diarrhoea are
the O-groups-6, -15, -78, -148, and others, they produce thermolabile and thermoresistant enterotoxins.
         Colienteritis begins acutely with high temperature (38-39 °C), and frequently with severe meteorism,
vomiting, diarrhoea, and general toxicosis. The disease usually occurs in infants of the first year of life.
         The infection is acquired from sick children or carriers. Pathogenic E. coli serovars are found on various
objects. It is assumed that colienteritis is transmitted not only by the normal route for enteric infections but also
through the respiratory tract by the droplets and dust.
         The pathogenesis of colienteritis depends entirely on the organism's condition. In prematurely born infants
and in infants during the first months of life the bactericidal activity of blood is considerably lower in respect to the
pathogenic E. coli serovars in comparison to the nonpathogenic types. The reactivity of the child's body at the time
of infection plays an important role in the mechanism of resistance to the pathogenic strains. The pathological
process develops mainly in the small intestine. Most probably, the mucous membrane of the small intestine in
particular is exposed to the action of thermolabile toxic substances. Serovars O-124, O-151 and others cause
diseases which are similar to dysentery.
         E. coli may cause colibacillosis in adults (peritonitis, meningitis, enteritis, toxinfections, cystitis, pyelitis,
pyelonephntis, angiocholitis, salpingooophontis, appendicitis, otitis, puerperal sepsis, etc.). Overstrain, exhaustion,
and conditions following infectious diseases facilitate the onset of various E. coli infections. In a number of cases
the organism is responsible for food poisoning.
         Immunity. In individuals who had suffered from diseases caused by pathogenic E. coli serovars, cross
immunity is not produced owing to which reinfection may occur. Over 85 per cent of E. coli strains contain
inhibiting substances, colicins, marked by antagonistic properties in relation to pathogenic microbes of the enteric
group, they are used as therapeutic and preventive agents, e.g. colibacterin (E. coli M 17, etc.).
         Besides this, E coli as well as other common inhabitants of the intestine are capable of synthesizing various
vitamins (K2, E, and group B) which are indispensable to the human organism. The ability of various E. coli
serovars to suppress the growth of Mycobacterium tuberculosis has also been observed. The suppression of E. coli
and other members of the biocoenosis may result in a chronic disease known as dysbacteriosis.
         Laboratory diagnosis. The patients' faeces, throat and nasal discharges, material obtained at autopsy
(blood, bile, liver, spleen, lungs, contents of the small and large intestine, pus), water, foodstuffs, and samples of
washings from objects and hands of staff of maternity hospitals, hospitals, and dairy kitchens are all used for
laboratory examination during colienteritis. If possible, faecal material should be inoculated immediately after it
has been collected. The throat and nasal discharges are collected with a sterile swab. Specimens of organs obtained
at autopsy are placed in separate sterile jars.
         The tested material is inoculated onto solid nutrient media (Endo's, Levin's) and, simultaneously, onto
Ploskirev's media and bismuth-sulphite agar for isolation of bacteria of the typhoid-paratyphoid and dysentery
group.Blood is first inoculated into broth and then subcultured on solid media when development of a septic
process is suspected. Pus is collected for examination in suppurative lesions. It is placed into a dry sterile vessel
and then inoculated onto the differential media of Endo or Levin. The pure culture isolate is identified by its
morphological, cultural, biochemical, serological, and biological properties.

                                                                                                                         2
The corresponding 0-group to which an enteropathogenic-serovars belong is determined by means of the
agglutination reaction after the K-antigen of the culture that is being studied has been destroyed by boiling.
         Besides, the immunofluorescence method employing type specific labelled sera is also used. It yields a
preliminary answer in one to two hours.
         In serological diagnosis of colienteritis beginning with the third to fifth day of the disease the indirect
haemagglutination reaction is used which excels the agglutination reaction in sensitivity. It is positive when the
antibody titre grows in the course of the diseased.
         Treatment. Patients with colienteritis are prescribed antibiotics (tetracycline with vitamins C, B 1 and B2)
and biopreparations (coli autovaccine, coli bacteriophage, colicin, bacterin, lactobacterin, bificol, bifidumbacterin).
Physiological solutions with glucose are injected for controlling toxicosis.
         Prophylaxis. To prevent diseases caused by pathogenic serovars of E. coli, special attention is given to
early identification of individuals suffering from colienteritis, and also to their hospitalization and effective
treatment. Regular examination of personnel is necessary in children's institutions as well as of mothers whose
children are suffering from dyspepsia. Considerable importance is assigned to observation of sanitary regulations in
children's institutions, infant-feeding centres, maternity hospitals, and nurseries. Protection of water and foodstuff's
from contamination with faeces, the control of flies, and gradual improvement of standards of hygiene of the
population are also particularly important.
         Sanitary significance of E. coli. This organism is widely spread in nature. It occurs in soil, water,
foodstuff's, and on various objects. For this reason E. coli serves as an indicator of faecal contamination of the
external environment.
       Detection of E. coli is of great importance in estimating the sanitary index of faecal contamination of water,
foodstuff's, soil, beverages, objects, and hand-washings. The degree of contamination of water, soil and foodstuff's
is determined by the coli titre or coli index.Faecal contamination of articles of use is estimated by qualitative
determination of the presence of E. coli.
       Pathogenicity of Escherichia coli. Although E. coli is part of the normal flora of the intestinal tract, it is
also the most common gram-negative pathogen responsible for nosocomially acquired septic shock, meningitis in
neonates, cystitis and pyelonephritis in women, and for several distinct forms of diarrheal disease and dysentery
affecting populations throughout the world. Strains of E coli capable of causing such diseases possess one or more
virulence factors that are not found in E. coli strains comprising the normal flora. Such virulence factors can be
characterized as follows, the capacity to adhere to specific mammalian cells; the ability to invade and grow
intracellularly in intestinal epithelial cells; the secretion of one or more enterotoxins that cause fluid loss, resulting
diarrhea; the formation of a cytotoxin that blocks protein synthesis, causing a hemorrhagic colitis; and the
possession of an antiphagocytic capsule that is responsible, at least in part, for the bacteremia and meningitis
caused by E. coli. In addition, the ability to obtain iron from transferrin or lactoferrin by the synthesis of iron-
binding siderophores markedly enhances the virulence of such strains through their ability to grow in host tissues.
No one strain of E. coli possesses all of these properties but all pathogenic strains must have one or more virulence
factors to produce disease.
       Diarrheal Diseases. Diarrhea kills more people worldwide than AIDS and cancer, with about five million
diarrheal deaths occurring annually primarily because of dehydration. Most of these occur in neonates and young
children, anda large number are caused by pathogenic E. coli. The disease in adults, known by many names such as
traveller’s diarrhea or Montezuma's revenge, may vary from a milddisease with several days of loose stools to a
severe and fatal cholera-like disease. Such life-threatening E. coli infections occur throughout the world but are
most common in developing nations.
       The virulence factors responsible for diarrheal diseaseare frequently encoded in plasmids, which may be
spread from one strain to another either through transduction : or by recombination. As a result, various
combinations of virulence factors have occurred, which has been used to place the diarrhea-producing strains of E.
coli into various groups based on the mechanism of disease production
       Enterotoxigenic Escherichia coli. Enterotoxin-producing E coli, called enterotoxigenic E.coli (ETEC),
produce one or both of two different toxins – a heat labile toxin called LT and a heat-stable toxin called ST. The
genetic ability to produce both LT and ST is controlled by DNA residing in transmissible plasmids called ent
plasmids. Both genes have been cloned, and the ST gene has been shown to possess the characteristics of a
transposon.
       HEAT-LABILE TOXIN. The heat-labile toxin LT, which is destroyed by heating at 65 °C for 30 minutes,
has been extensively purified, and its mode of action is identical to that described for cholera toxin (CT). LT has a
molecula weight of about 86,000 daltons and is composed of two subunits, A and B Subunit A consists of one
moleculeof Ai (24,000 daltons) and one molecule of A2 (5000daltons) linked by a disulfide bridge. Each A unit is
joined noncovalently to five B subunits.

                                                                                                                        3
Like CT, LT causes diarrhea by stimulating the activity of a membrane-bound adenylate cyclase.This results
in the conversion of ATP to cyclic AMP (cAMP).
       cAMP induce the active secretion of Cl– and inhibit the absorption of NaCI, creating an electrolyte imbalance
across the intestinal mucosa, resulting in the loss of copious quantities of fluid and elec-trolytes from the intestine.
       The mechanism by which LT stimulates the activity of the adenylate cyclase is as follows: (1) The B subunit
of the toxin binds to a specific cell receptor, GM1 ganglioside, (2) the A1 subunit is released from the toxin and
enters the cell; and (3) the A1 subunit cleaves nicotinamide-adenic dinucleonde (NAD) into nicotinamide and ADP-
ribose and, together with a cellular ADP-ribosylating factor, transfers the ADP-ribose to aGTP-binding protein.
The ADP-ribosylation of the GTP-binding protein inhibits a GTPase activity of the binding protein, leading to
increased stability of the catalytic cornplex responsible for adenylate cyclase activity. This results in an amplified
activity of the cyclase and a corresponding increase in the amount of cAMP produced.
       Two antigenically distinct heat labile toxins are produced by various strains of E. coli. LT-I is structurally
andantigenically related to CT to an extent that anti-CT will neutralize LT I LT-II has, on rare occasions, been
isolated from the feces of humans with diarrhea, but it is most frequently isolated from feces of water buftalos and
cows LT-II is biologically similar to LT-I, but it is notneutralized by either anti-LT-I or anti-CT.
       LT will bind to many types of mammalian cells, and its ability to stimulate adenylate cyclase can be assayed
incell cultures.
       A report has also shown that CT stimulated an increase in prostaglandin E (PGE), and that PGE1 and PGE2
caused a marked fluid accumulation in the ligated lumen of rabbit intestinal segments. The mechanism whereby CT
induces PGE release is unknown.
       HEAT-STABLE TOXIN The heat-stable toxin STa consists of a family of small, heterogeneous
polypeptides of 1500 to 2000 daltons that are not destroyed by heating at 100 °Cfor 30 minutes. STa has no effect
on the concentration of cAMP, but it does cause a marked increase the cellular levels of cyclic GMP (cGMP).
cGMP causes an inhibition of the cotransport of NaCI across the intestinal wall, suggesting that the action of STa
may be primarily antiabsorptive compared with that of LT, which is both antiabsorptive and secretory.
       STa stimulates guanylate cyclase only in intestinal cells, indicating that such cells possess a unique
receptorfor Sta. The cell receptor for STa is known to be either tightly coupled to, or a part of, a particulate form of
guanylate cyclase located in the brush border membranes of intestinal mucosal cells. Also, intimately associated
with this complex is a cGMP-dependent protein kinase that phosphorylates a 25,000 dalton protein in the brush
border. It has been proposed that this phosphorylated protein might be the actual mediator for the toxin-induced
iontransport alterations that lead to fluid loss. The usual assay for STa is to inject the toxin intragastrically into a 1
– to 4-day old suckling mouse and measure intestinal fluid accumulation (as a ratio of intestinal/remaining body
weight) after 4 hours. STa may also be assayed directly by measuring its effect on the increase in guanylate
cyclasein homogenized intestinal epithelial cells.
       A second heat stable toxin that is produced by somestrains of E. coli has been termed STb. This toxin is
inactivein suckling mice but will produce diarrhea in weaned piglets. STb producers have not been isolated from
humans. It does not seem to increase the level of adenylate or guanylate cyclase in intestinal mucosal cells, but
maystimulate the synthesis of prostaglandin E2. The end resuit is to enhance net bicarbonate ion secretion.
       COLONIZATION FACTORS. Animals also are subjects to infections by their own strains of ETEC, and
such infections in newborn animals may result in death from the loss of fluids and electrolytes. Extensive studies of
strains infecting newborn calves and piglets (as well as humans) have revealed that, in addition to producing an
enterotoxin, such strains possess one of several fimbriate surface structures that specifically adhere to the epithelial
cellslining the small intestine. These antigens (K-88 for swine strains, and K-99 for cattle) usually are fimbriate
structures that cause the toxin-producing organisms to adhere to and colonize the small intestine. The need for this
colonizing ability is supported by the fact that antibodies directed against the colonizing fimbriae are protective.
       Analogous human ETEC strains also possess fimbriate structures that have been designated as
colonizationfactors (CFA). At least five such serologicallydifferent factors, CFA/I, CFA/II, CFA/III, E8775,
andCFA/V, have been described. Interestingly, these colonization factors also are plasmid mediated, and single
plasmids have been described that carry genes for both CFA/I and STa.
       Enterohemorrhagic Escherichia coli. The enterohemorrhagic E. coli (EHEC) were first described in 1982
when they were shown to be the etiologic agent of hemorrhagic colitis, a disease characterized by severe abdominal
cramps and a copious, bloody diarrhea. These organisms are also known to cause a condition termed hemolytic-
uremic syndrome (HUS), which is manifested by a hemolytic anemia, thrombocytopenia (decrease in the number
of blood platelets), and acuterenal failure. HUS occurs most frequently in children.
         Although most initially recognized EHEC belong to serotype O157:H7, other EHEC serotypes such as
O26, O111, O128, and O143 have been recognized. These organisms are not invasive, but they do possess a 60-
megadalton plasmid that encodes for a fimbrial antigen that adheres to intestinal epithelium. In addition, the EHEC

                                                                                                                        4
are lysogenic for one or more bacteriophages that encode for the production of one or both of two antigenically
distinct toxins. These toxins are biologically identical and antigenically similar to the toxins formed by Shigella
dysenteriae (Shiga's bacillus), and are designated as Shiga-like toxin I (SLT-I) and Shiga-like toxin II (SLT II).
Because the Shiga-like toxins initially were characterized by their ability to kill Vero cells, a cell line developed
from African green monkey kidney cells, they also arecalled Verotoxin I and Verotoxin II.
       SLT I consists of an A subunit and five B subunits. The sequence of the B subunit from S. dysenteriae type 1
is identical to that of the B subunit of SLT I. The B subunit binds specifically to a glycolipid in microvillus
membranes, and the released A subunit stops protein synthesis by inactivating the 60S ribosomal subunit. This
inactivation results from the N-glycosidase activity of the toxin, which cleaves off an adenine molecule (A-4324)
from the 28S ribosomal RNA, causing a structural modification of the 60S subunit, resulting in a reduced affinity
for EF-1 and, thus, an inhibition of aminoacyl- tRNA binding. The consequence of toxin action is a cessation of
protein synthesis, the sloughing off of dead cells, anda bloody diarrhea. Notice that SLT 1 carries out the same
reaction as the plant toxins ricin and abrin.
       SLT II is biologically similar to SLT I, but because only a 50% to 60% homology exists between the two
toxins, it is not surprising that they are antigenically distinct. Interestingly, both STL I and STL-II can be
transferred to nontoxin producing strains of E. coli by transduction.
       Outbreaks of hemorrhagic colitis have been traced to contaminated food as well as to person to person
transmission in nursing homes and day care centres. Contaminated, undercooked hamburger meat seems to be the
most frequently implicated source of food borne illnesses followed by contaminated milk and water, indicating
thatcattle are a common reservoir for EHEC. Of note is that E. coli 0157:H7 has been shown to survive up to 9
months at -20°C in ground beef.
       Thus, the EHEC are able to cause hemorrhagic colitis as a result of their ability to adhere to the intestinal
mucosa, and they presumably destroy the intestinal epithelial lining through their secretion of Shiga like toxins.
The mechanism whereby the EHEC cause HUS is unclear but seems to follow bloodstream carriage of SLT II to
the kidney. Experimental results have shown that humanrenal endothelial cells contain high levels of receptor for
SLT-2. Moreover, in the presence of interleukin (IL)1/β, the amount of receptor increases, enhancing the
internalization of the toxin and the death of the cell.
       The section, "A Closer Look," describes several epidemics of hemorrhagic colitis that have occurred in the
United States and techniques that are used for the identification of this serotype
       Enteroinvasive Escherichia coli
       The disease produced by the enteroinvasive E. coli (EIEC) is indistinguishable from the dysentery produced
by members of the genus Shigella, although the shigellae seem to be more virulent.The key virulence factor
required by the EIEC is the ability to invade the epithelial cells.
       EIEC INVASION. The specific property that provides these organisms with their invasive potential is far
from understood. It is known, however, that this ability is encoded in a plasmid and that the loss of the plasmid
results in a loss of invasive ability and a loss of virulence. Moreover, the shigellae seem to possess the same
plasmid, because Western blots show that shigellae and EIEC plasmids express polypeptides that are similar in
molecular weight and antigenicity.
       Enteropathogenic Escherichia coli. The enteropathogenic E. coli (EPEC) are diffusely adherent organisms
that are particularly important in infant diarrhea occurring in developing countries, where they may cause a
mortality rate as high as a 50%. They comprise a mixture of organisms that seem to produce diarrhea by a two-step
process. The classic EPEC exist among a dozen or so different serotypes, all of which are characterized by the
possession of a 55 to 65-megadalton plasmid that encodes for an adhesin termed EPEC adherence factor (EAF).
EAF causes a localized adherence of the bacteria to enterocytes of the small bowel, resulting in distinct
microcolonies. This is followed by the formation of unique pedestal-like structures bearing the adherent bacteria.
These structures have been termed attaching and effacing lesions. The ability to form the effacing lesion resides in
an attaching and effacing gene (eae). The lesions are characterized by a loss of microvilli and a rearrangement of
the cytoskeleton, with a proliferation of filamentous actin beneath are as of bacterial attachment.
       Thus, the ability of the EPEC to cause diarrhea involves two distinct genes, EAF and eae. The end result is
anelevated intracellular Ca+2 level in the intestinal epithelialcells and the initiation of signal transduction, leading to
protein tyrosine phosphorylation of at least two eucaryotic proteins.
       EPEC strains routinely have been considered noninvasive, but data have indicated that such strains can
invadeepithelial cells in culture. However, EPEC strains do not typically cause a bloody diarrhea, and the
significance of cell invasion during infection remains uncertain.
       Other Diairhea-Producing Escherichia coli. All possible combinations, deletions, or additions of the
various virulence factors responsible for intestinal fluid loss result in diarrhea producing strains that do not fit the
categories already described. Such has been found tobe the case.

                                                                                                                         5
The most recent of these has been termed the enteroaggregative E. coli. These strains seem to cause diarrhea
through their ability to adhere to the intestinal mucosa and possibly by yet a new type of enterotoxin. It seems
possible that the acquisition of other virulence factors may result in the discovery of additional pathogenic strains
of E. coli.
       E. coli Urinary Tract Infections. Escherichia coli is the most common cause of urinary tract infections of
the bladder (cystitis) and, less frequently, of the kidney (pyelonephritis). In either case, infections usually are of an
ascending type (enter the bladder from the urethra and enter the kidneys from the bladder). Many infections occur
in young female patients, in persons with urinary tract obstructions, and in persons requiring urinary catheters, and
they occur frequently in otherwise healthy women. Interestingly, good data support the postulation that certain
serotypes of E. coli are more likely to cause pyelonephritis than others. Thus, the ability to produce P-fimbriae (so
called because of their ability to bind to P blood group antigen) has been correlated with the ability to produce
urinary tract infections, seemingly by mediating the adherence of the organisms to human uroepithelial cells. Of
note is that the rate of nosocomial urinary tract infection per person-day was significantly greater in patients with
diarrhea, particularly in those with an indwelling urinary catheter.
       In addition to fimbrial adhesins, a series of afimbrial adhesins has been reported. Their role in disease is not
yet firmly established, but it has been demonstrated that at least one afimbrial adhesins mediated specific binding to
uroepithelial cells.
       Recurrent urinary tract infections in premenopausal, sexually active women frequently can be prevented by
the postcoital administration of a single tablet of an antibacterial agent such as trimethoprim-sulfamethoxazole,
cinoxacin, or cephalexin.
       E. coli Systemic Infections. About 300,000 patients in United States hospitals develop gram-negative
bacteremia annually, and about 100,000 of these persons the of septic shock. As might be guessed, E. coli is the
most common organism involved in such infections. The ultimate cause of death in these cases is an endotoxin-
induced synthesis and release of tumor necrosis factor-alpha and IL-1, resulting in irreversible shock.
       The newborn is particularly susceptible to meningitis, especially during the first month of life. A survey of
132 cases of neonatal meningitis occurring in the Netherlands reported that 47% resulted from E. coli and 24%
from group B streptococci. Notice that almost 90% of all cases of E. coli meningitis are caused by the K1 strain,
which possesses a capsule identical to that occurring on group B meningococci.

                                         Table 1: Escherichia   coli Virulence Factors
                          Diarrhea-producing                     Virulence Factors
                                 E. coli
                         Enteroroxigenic E. coli             Heat-labile toxin (LT)
                                                      Heat-stable toxin (ST) Colonization
                                                                factors (fimbriae)
                          Enterohernorrhagic E.             Shiga like toxin (SLT-I)
                                  coli              Shiga like toxin II (SLF-II) Colonisation
                                                                factors (fimbriae)
                          Enteroinvasive E. coli        Ability to invade epithelial cells
                                                            Shiga like toxin (SLT-I)?
                                                          Shiga like toxin II (SLF-II)?

                           Enteropathogenic E.          Adhesin factor for epithelial cells
                                   coli
                              Urinary trace                         P- fimbriae
                                infections
                               Meningitis                           K-1 capsule


4. Student’s independent study program
      1. General characteristics of Enterobacteriaceae.
      2. Structure and tinctorial properties of Escherichia coli. Cultivation.
      3. Biochemical properties of E. colі.
      4. Peculiarities of antigenic structure of E. colі. Pathogenic serovars of E. coli.
      5. Virulence factors of E. colі and their action on organism (pili, colicines, endotoxins, protein toxins).
      6. Enteropathogenic, enteroinvasive, enterotoxigenic, enterohemorrhagic E. coli. Diseases they are caused.


                                                                                                                       6
7. Methods of diagnosis of colienterites and other diseases, which caused by E. coli. Peculiarities of getting
of tested material for bacteriological examination and its main stages. Significance of serological identification of
causative agents.
       8. Prophylaxis of colienterites.
5. Students’ practical activities:
       1. To prepare a smear from E. coli, to stain it by Gram’s method and to examine under microscope.
       2. To examine the growth perculiarities of E. coli on MPA, Endo’s, Levin’s, Ploskirev’s media, in MPB.
       3. To examine biochemical activity of E. coli on Hiss’ media.
       4. To carry out presumptive agglutination test with typical sera and culture of an unknown serovar of E. coli.
       5. To familiarize with specific diagnostic agglutination Sera.
       6. To end diagnostic of inflammatory process causing by staphilococci. Evaluate sensitivity of isolated strain
to antibiotics.


      6. Control questions and tests
      Select the correct answers.
      1. E. coli has such properties:
          A – peritrichate; B – Gram-negative; C –does not have flagella; D – gram-positive; E – forms spores.
      2. A – grows on Endo’s and Levin’s media; b – on media with lactose the colonies are colour; c – on media
          with lactose the colonies are colourless; e – does not grow without presence of native protein.
      3. A – ferments all carbohydrates of Hiss’ media with production of an acid and gas; b – does not ferment a
      saccharose; c – produces indole; d – produces hydrogen sulfide; e – fermentats all carbohydrates of
      Hiss’media with the exception of a saccharose.
      3. What antigen do determine serological groups of Escherichia; in what immunological reaction it can be
          determined? A – K, precipitation test; b – Н, agglutination test; c – O, agglutination test; d – K and Н,
          agglutination test; e – O, flocculation test.
      5. Characteristic of pathogenic serovars: a – enteropathogenic E. coli produce enterotoxins with adenylate
          cyclase activity; b – enteroinvasive Escherichia coli cause dysentery-like diseases; c – enterotoxigenic
          Escherichia coli are not capable to parasitize in the cells; d – enterotoxigenic Escherichia coli cause
          dysentery-like diseases; e – enterotoxigenic Escherichia coli secrete a toxin with adenylate cyclase
          activity.
      6. One can differentiate commensal E. coli from enteropathogenic E. coli using: a – biochemical properties;
          b –endotoxin production; c – antigenic structure; d –pathogenicity for animals; e – resistance to
          antibiotics




7. List of literature:
1.S. Gaidash, V.V. Flegontova, Microbiology, virology and immunology, Lugansk, 2004,part 2,
chapter24, p. 171-182.




I




                                                                                                                    7

Contenu connexe

Tendances

Enterobacteriaceae
EnterobacteriaceaeEnterobacteriaceae
EnterobacteriaceaeL Syd
 
Environmental microbiology 2009
Environmental microbiology 2009Environmental microbiology 2009
Environmental microbiology 2009aiiinura
 
Normal Microflora of Human Body. Dysbacteriosis. Prophylaxis & Treatment
Normal Microflora of Human Body. Dysbacteriosis. Prophylaxis & TreatmentNormal Microflora of Human Body. Dysbacteriosis. Prophylaxis & Treatment
Normal Microflora of Human Body. Dysbacteriosis. Prophylaxis & TreatmentEneutron
 
Microbiology Bio 127 Normal Flora of the Human Body
Microbiology Bio 127 Normal Flora of the Human BodyMicrobiology Bio 127 Normal Flora of the Human Body
Microbiology Bio 127 Normal Flora of the Human BodyShaina Mavreen Villaroza
 
Diarrheagenic escherichia coli
Diarrheagenic escherichia coliDiarrheagenic escherichia coli
Diarrheagenic escherichia coliMARIO ARTURO DIAZ
 
Normal microbial flora and also its role in human defence system assignment
Normal microbial flora and also its role in human defence system assignmentNormal microbial flora and also its role in human defence system assignment
Normal microbial flora and also its role in human defence system assignmentShahbaz Ahmad
 
Taxonomy, phylogeny, epidemiology rupinder
Taxonomy, phylogeny, epidemiology rupinderTaxonomy, phylogeny, epidemiology rupinder
Taxonomy, phylogeny, epidemiology rupinderuashish14
 
Human normal flora
Human normal floraHuman normal flora
Human normal floraHimst Edu
 
Environmental microbiology
Environmental microbiology Environmental microbiology
Environmental microbiology Ghassan Hadi
 
Microbiology of water, soil & air
Microbiology of water, soil & airMicrobiology of water, soil & air
Microbiology of water, soil & airMuneeba Sheikh
 
Commensal and pathogens
Commensal  and pathogensCommensal  and pathogens
Commensal and pathogensMeher Rizvi
 
(E.coli , gastroentritis)
(E.coli , gastroentritis) (E.coli , gastroentritis)
(E.coli , gastroentritis) lekshmirpillai31
 
Study of E. coli on basis of Morphological, Cultural, Biochemical, clinical a...
Study of E. coli on basis of Morphological, Cultural, Biochemical, clinical a...Study of E. coli on basis of Morphological, Cultural, Biochemical, clinical a...
Study of E. coli on basis of Morphological, Cultural, Biochemical, clinical a...AbulAnsari5
 

Tendances (20)

Enterobacteriaceae
EnterobacteriaceaeEnterobacteriaceae
Enterobacteriaceae
 
Environmental microbiology 2009
Environmental microbiology 2009Environmental microbiology 2009
Environmental microbiology 2009
 
Normal Microflora of Human Body. Dysbacteriosis. Prophylaxis & Treatment
Normal Microflora of Human Body. Dysbacteriosis. Prophylaxis & TreatmentNormal Microflora of Human Body. Dysbacteriosis. Prophylaxis & Treatment
Normal Microflora of Human Body. Dysbacteriosis. Prophylaxis & Treatment
 
Microbiology Bio 127 Normal Flora of the Human Body
Microbiology Bio 127 Normal Flora of the Human BodyMicrobiology Bio 127 Normal Flora of the Human Body
Microbiology Bio 127 Normal Flora of the Human Body
 
Diarrheagenic escherichia coli
Diarrheagenic escherichia coliDiarrheagenic escherichia coli
Diarrheagenic escherichia coli
 
Normal microbial flora and also its role in human defence system assignment
Normal microbial flora and also its role in human defence system assignmentNormal microbial flora and also its role in human defence system assignment
Normal microbial flora and also its role in human defence system assignment
 
Taxonomy, phylogeny, epidemiology rupinder
Taxonomy, phylogeny, epidemiology rupinderTaxonomy, phylogeny, epidemiology rupinder
Taxonomy, phylogeny, epidemiology rupinder
 
Normal Flora
Normal FloraNormal Flora
Normal Flora
 
Lec 07. Normal flora
Lec 07.  Normal flora  Lec 07.  Normal flora
Lec 07. Normal flora
 
Chapter vii normal flora
Chapter vii normal floraChapter vii normal flora
Chapter vii normal flora
 
Normal microflora
Normal microflora Normal microflora
Normal microflora
 
Human normal flora
Human normal floraHuman normal flora
Human normal flora
 
Environmental microbiology
Environmental microbiology Environmental microbiology
Environmental microbiology
 
E. coli
E. coli  E. coli
E. coli
 
Microbiology of water, soil & air
Microbiology of water, soil & airMicrobiology of water, soil & air
Microbiology of water, soil & air
 
Commensal and pathogens
Commensal  and pathogensCommensal  and pathogens
Commensal and pathogens
 
Aeromonas
AeromonasAeromonas
Aeromonas
 
Basic Microbiology
Basic MicrobiologyBasic Microbiology
Basic Microbiology
 
(E.coli , gastroentritis)
(E.coli , gastroentritis) (E.coli , gastroentritis)
(E.coli , gastroentritis)
 
Study of E. coli on basis of Morphological, Cultural, Biochemical, clinical a...
Study of E. coli on basis of Morphological, Cultural, Biochemical, clinical a...Study of E. coli on basis of Morphological, Cultural, Biochemical, clinical a...
Study of E. coli on basis of Morphological, Cultural, Biochemical, clinical a...
 

En vedette

Extra credit powerpoint
Extra credit powerpointExtra credit powerpoint
Extra credit powerpointklosin
 
Bio 127 lec 4a Microbiology Topic: Nutrition and Cultivation of Microorganis...
Bio 127 lec 4a Microbiology Topic: Nutrition and Cultivation of  Microorganis...Bio 127 lec 4a Microbiology Topic: Nutrition and Cultivation of  Microorganis...
Bio 127 lec 4a Microbiology Topic: Nutrition and Cultivation of Microorganis...Shaina Mavreen Villaroza
 
Dark field microscopy
Dark field microscopyDark field microscopy
Dark field microscopyCHARLIE
 
Nutrition, cultivation and isolation of bacteria
Nutrition, cultivation and isolation of bacteriaNutrition, cultivation and isolation of bacteria
Nutrition, cultivation and isolation of bacteriaTanuja Bisht
 
Pure culture technic
Pure culture technicPure culture technic
Pure culture technicRitesh ranjan
 
Media in microbiology
Media in microbiologyMedia in microbiology
Media in microbiologyMusa Khan
 
science notes eng medium
science notes eng mediumscience notes eng medium
science notes eng mediumshashi kumar
 

En vedette (8)

Extra credit powerpoint
Extra credit powerpointExtra credit powerpoint
Extra credit powerpoint
 
Bio 127 lec 4a Microbiology Topic: Nutrition and Cultivation of Microorganis...
Bio 127 lec 4a Microbiology Topic: Nutrition and Cultivation of  Microorganis...Bio 127 lec 4a Microbiology Topic: Nutrition and Cultivation of  Microorganis...
Bio 127 lec 4a Microbiology Topic: Nutrition and Cultivation of Microorganis...
 
Dark field microscopy
Dark field microscopyDark field microscopy
Dark field microscopy
 
Nutrition, cultivation and isolation of bacteria
Nutrition, cultivation and isolation of bacteriaNutrition, cultivation and isolation of bacteria
Nutrition, cultivation and isolation of bacteria
 
Pure culture technic
Pure culture technicPure culture technic
Pure culture technic
 
Culture media & methods
Culture media & methodsCulture media & methods
Culture media & methods
 
Media in microbiology
Media in microbiologyMedia in microbiology
Media in microbiology
 
science notes eng medium
science notes eng mediumscience notes eng medium
science notes eng medium
 

Similaire à Bohomolets Microbiology Lesson #4

Enterobacteria Microbiology
Enterobacteria MicrobiologyEnterobacteria Microbiology
Enterobacteria MicrobiologyAntonBelyaev7
 
2_5193183418749290508.pptx
2_5193183418749290508.pptx2_5193183418749290508.pptx
2_5193183418749290508.pptxnedalalazzwy
 
Enterobacteriaceae
EnterobacteriaceaeEnterobacteriaceae
EnterobacteriaceaeBruno Mmassy
 
E. coli (Morphology, Growth Requirements and Genetics)
E. coli (Morphology, Growth Requirements and Genetics)E. coli (Morphology, Growth Requirements and Genetics)
E. coli (Morphology, Growth Requirements and Genetics)Siddhartha Dan
 
E.coli and others dr .ihsan alsaimary
E.coli and others dr .ihsan alsaimaryE.coli and others dr .ihsan alsaimary
E.coli and others dr .ihsan alsaimarydr.Ihsan alsaimary
 
Characterization of shiga toxin in escherichia coli during
Characterization of shiga toxin in escherichia coli duringCharacterization of shiga toxin in escherichia coli during
Characterization of shiga toxin in escherichia coli duringLuz Marie
 
Picornaviruses. Enteroviruses. Polyviruses. Coxsackieviruses. Echoviruses
Picornaviruses. Enteroviruses. Polyviruses. Coxsackieviruses. EchovirusesPicornaviruses. Enteroviruses. Polyviruses. Coxsackieviruses. Echoviruses
Picornaviruses. Enteroviruses. Polyviruses. Coxsackieviruses. EchovirusesEneutron
 
Escherichia coli
Escherichia coliEscherichia coli
Escherichia coliJosephSmrj
 
Infections on surfaces.pptx
Infections on surfaces.pptxInfections on surfaces.pptx
Infections on surfaces.pptxomarduski321
 
E coli lectur revised alpana
E coli lectur revised alpanaE coli lectur revised alpana
E coli lectur revised alpanaBruno Mmassy
 
Bohomolets Microbiology Lesson #6
Bohomolets Microbiology Lesson #6Bohomolets Microbiology Lesson #6
Bohomolets Microbiology Lesson #6Dr. Rubz
 
sinh bệnh học escherichia coli
sinh bệnh học escherichia colisinh bệnh học escherichia coli
sinh bệnh học escherichia coliSoM
 
Bohomolets Microbiology Lecture #19
Bohomolets Microbiology Lecture #19Bohomolets Microbiology Lecture #19
Bohomolets Microbiology Lecture #19Dr. Rubz
 
Enterobacteriaceae.pptx
Enterobacteriaceae.pptxEnterobacteriaceae.pptx
Enterobacteriaceae.pptxMusFa1
 
Opportunistic Infections. Genera Proteus. Klebsiella & Pseudomonas. Hospital ...
Opportunistic Infections. Genera Proteus. Klebsiella & Pseudomonas. Hospital ...Opportunistic Infections. Genera Proteus. Klebsiella & Pseudomonas. Hospital ...
Opportunistic Infections. Genera Proteus. Klebsiella & Pseudomonas. Hospital ...Eneutron
 
Human Health and Diseases.pptx
Human Health and Diseases.pptxHuman Health and Diseases.pptx
Human Health and Diseases.pptxNoname451849
 
Pathogenic Enterobacteriaceae
Pathogenic Enterobacteriaceae Pathogenic Enterobacteriaceae
Pathogenic Enterobacteriaceae Rupesh Sharma
 

Similaire à Bohomolets Microbiology Lesson #4 (20)

Enterobacteria Microbiology
Enterobacteria MicrobiologyEnterobacteria Microbiology
Enterobacteria Microbiology
 
2_5193183418749290508.pptx
2_5193183418749290508.pptx2_5193183418749290508.pptx
2_5193183418749290508.pptx
 
Enterobacteriaceae
EnterobacteriaceaeEnterobacteriaceae
Enterobacteriaceae
 
E. coli (Morphology, Growth Requirements and Genetics)
E. coli (Morphology, Growth Requirements and Genetics)E. coli (Morphology, Growth Requirements and Genetics)
E. coli (Morphology, Growth Requirements and Genetics)
 
E.coli and others dr .ihsan alsaimary
E.coli and others dr .ihsan alsaimaryE.coli and others dr .ihsan alsaimary
E.coli and others dr .ihsan alsaimary
 
Characterization of shiga toxin in escherichia coli during
Characterization of shiga toxin in escherichia coli duringCharacterization of shiga toxin in escherichia coli during
Characterization of shiga toxin in escherichia coli during
 
Microb e.coli
Microb e.coliMicrob e.coli
Microb e.coli
 
Entero bacteriaceae
Entero bacteriaceaeEntero bacteriaceae
Entero bacteriaceae
 
Picornaviruses. Enteroviruses. Polyviruses. Coxsackieviruses. Echoviruses
Picornaviruses. Enteroviruses. Polyviruses. Coxsackieviruses. EchovirusesPicornaviruses. Enteroviruses. Polyviruses. Coxsackieviruses. Echoviruses
Picornaviruses. Enteroviruses. Polyviruses. Coxsackieviruses. Echoviruses
 
Escherichia coli
Escherichia coliEscherichia coli
Escherichia coli
 
Infections on surfaces.pptx
Infections on surfaces.pptxInfections on surfaces.pptx
Infections on surfaces.pptx
 
E coli lectur revised alpana
E coli lectur revised alpanaE coli lectur revised alpana
E coli lectur revised alpana
 
Bohomolets Microbiology Lesson #6
Bohomolets Microbiology Lesson #6Bohomolets Microbiology Lesson #6
Bohomolets Microbiology Lesson #6
 
sinh bệnh học escherichia coli
sinh bệnh học escherichia colisinh bệnh học escherichia coli
sinh bệnh học escherichia coli
 
Bohomolets Microbiology Lecture #19
Bohomolets Microbiology Lecture #19Bohomolets Microbiology Lecture #19
Bohomolets Microbiology Lecture #19
 
Enterobacteriaceae.pptx
Enterobacteriaceae.pptxEnterobacteriaceae.pptx
Enterobacteriaceae.pptx
 
Opportunistic Infections. Genera Proteus. Klebsiella & Pseudomonas. Hospital ...
Opportunistic Infections. Genera Proteus. Klebsiella & Pseudomonas. Hospital ...Opportunistic Infections. Genera Proteus. Klebsiella & Pseudomonas. Hospital ...
Opportunistic Infections. Genera Proteus. Klebsiella & Pseudomonas. Hospital ...
 
Human Health and Diseases.pptx
Human Health and Diseases.pptxHuman Health and Diseases.pptx
Human Health and Diseases.pptx
 
Pathogenic Enterobacteriaceae
Pathogenic Enterobacteriaceae Pathogenic Enterobacteriaceae
Pathogenic Enterobacteriaceae
 
Food hazard & non bacterial agents of foodborne illness
Food hazard & non bacterial agents of foodborne illnessFood hazard & non bacterial agents of foodborne illness
Food hazard & non bacterial agents of foodborne illness
 

Plus de Dr. Rubz

HIV discrimination among health providers in Malaysia by Dr Rubz
HIV discrimination among health providers in Malaysia by Dr RubzHIV discrimination among health providers in Malaysia by Dr Rubz
HIV discrimination among health providers in Malaysia by Dr RubzDr. Rubz
 
HIV/AIDS data Hub Asia Pacific -Malaysia 2014
HIV/AIDS data Hub Asia Pacific -Malaysia  2014HIV/AIDS data Hub Asia Pacific -Malaysia  2014
HIV/AIDS data Hub Asia Pacific -Malaysia 2014Dr. Rubz
 
Regional Overview in HIV by Steve Kraus
Regional Overview in HIV by Steve KrausRegional Overview in HIV by Steve Kraus
Regional Overview in HIV by Steve KrausDr. Rubz
 
Game Changer by Dr Shaari Ngadiman
Game Changer by Dr Shaari NgadimanGame Changer by Dr Shaari Ngadiman
Game Changer by Dr Shaari NgadimanDr. Rubz
 
Pre and post HIV counseling (VCT)
Pre and post HIV counseling (VCT)Pre and post HIV counseling (VCT)
Pre and post HIV counseling (VCT)Dr. Rubz
 
Ulc auction final
Ulc auction finalUlc auction final
Ulc auction finalDr. Rubz
 
Testicular cancer for public awareness by Dr Rubz
Testicular cancer for public awareness by Dr RubzTesticular cancer for public awareness by Dr Rubz
Testicular cancer for public awareness by Dr RubzDr. Rubz
 
Prostate cancer for public awareness by DR RUBZ
Prostate cancer for public awareness by DR RUBZProstate cancer for public awareness by DR RUBZ
Prostate cancer for public awareness by DR RUBZDr. Rubz
 
Breast Cancer for public awareness by Dr Rubz
Breast Cancer for public awareness by Dr  RubzBreast Cancer for public awareness by Dr  Rubz
Breast Cancer for public awareness by Dr RubzDr. Rubz
 
Sex work presentation 9.18.13a
Sex work presentation 9.18.13aSex work presentation 9.18.13a
Sex work presentation 9.18.13aDr. Rubz
 
Rapid interpretation of ECG
Rapid interpretation of ECGRapid interpretation of ECG
Rapid interpretation of ECGDr. Rubz
 
Hernia by Dr. Rubzzz
Hernia by Dr. RubzzzHernia by Dr. Rubzzz
Hernia by Dr. RubzzzDr. Rubz
 
Benign breast disease by Dr. Kong
Benign breast disease by Dr. KongBenign breast disease by Dr. Kong
Benign breast disease by Dr. KongDr. Rubz
 
Breast CA by Dr. Celine Tey
Breast CA by Dr. Celine TeyBreast CA by Dr. Celine Tey
Breast CA by Dr. Celine TeyDr. Rubz
 
Other scrotal swelling by Dr. Teo
Other scrotal swelling by Dr. TeoOther scrotal swelling by Dr. Teo
Other scrotal swelling by Dr. TeoDr. Rubz
 
Ventral hernia by Dr Teo
Ventral hernia by Dr TeoVentral hernia by Dr Teo
Ventral hernia by Dr TeoDr. Rubz
 
Testicular torsion by Dr Teo
Testicular torsion by Dr TeoTesticular torsion by Dr Teo
Testicular torsion by Dr TeoDr. Rubz
 
Uk malaria treatment guideline
Uk malaria treatment guidelineUk malaria treatment guideline
Uk malaria treatment guidelineDr. Rubz
 
Tuberculosis summary
Tuberculosis summaryTuberculosis summary
Tuberculosis summaryDr. Rubz
 
Shock summary
Shock summaryShock summary
Shock summaryDr. Rubz
 

Plus de Dr. Rubz (20)

HIV discrimination among health providers in Malaysia by Dr Rubz
HIV discrimination among health providers in Malaysia by Dr RubzHIV discrimination among health providers in Malaysia by Dr Rubz
HIV discrimination among health providers in Malaysia by Dr Rubz
 
HIV/AIDS data Hub Asia Pacific -Malaysia 2014
HIV/AIDS data Hub Asia Pacific -Malaysia  2014HIV/AIDS data Hub Asia Pacific -Malaysia  2014
HIV/AIDS data Hub Asia Pacific -Malaysia 2014
 
Regional Overview in HIV by Steve Kraus
Regional Overview in HIV by Steve KrausRegional Overview in HIV by Steve Kraus
Regional Overview in HIV by Steve Kraus
 
Game Changer by Dr Shaari Ngadiman
Game Changer by Dr Shaari NgadimanGame Changer by Dr Shaari Ngadiman
Game Changer by Dr Shaari Ngadiman
 
Pre and post HIV counseling (VCT)
Pre and post HIV counseling (VCT)Pre and post HIV counseling (VCT)
Pre and post HIV counseling (VCT)
 
Ulc auction final
Ulc auction finalUlc auction final
Ulc auction final
 
Testicular cancer for public awareness by Dr Rubz
Testicular cancer for public awareness by Dr RubzTesticular cancer for public awareness by Dr Rubz
Testicular cancer for public awareness by Dr Rubz
 
Prostate cancer for public awareness by DR RUBZ
Prostate cancer for public awareness by DR RUBZProstate cancer for public awareness by DR RUBZ
Prostate cancer for public awareness by DR RUBZ
 
Breast Cancer for public awareness by Dr Rubz
Breast Cancer for public awareness by Dr  RubzBreast Cancer for public awareness by Dr  Rubz
Breast Cancer for public awareness by Dr Rubz
 
Sex work presentation 9.18.13a
Sex work presentation 9.18.13aSex work presentation 9.18.13a
Sex work presentation 9.18.13a
 
Rapid interpretation of ECG
Rapid interpretation of ECGRapid interpretation of ECG
Rapid interpretation of ECG
 
Hernia by Dr. Rubzzz
Hernia by Dr. RubzzzHernia by Dr. Rubzzz
Hernia by Dr. Rubzzz
 
Benign breast disease by Dr. Kong
Benign breast disease by Dr. KongBenign breast disease by Dr. Kong
Benign breast disease by Dr. Kong
 
Breast CA by Dr. Celine Tey
Breast CA by Dr. Celine TeyBreast CA by Dr. Celine Tey
Breast CA by Dr. Celine Tey
 
Other scrotal swelling by Dr. Teo
Other scrotal swelling by Dr. TeoOther scrotal swelling by Dr. Teo
Other scrotal swelling by Dr. Teo
 
Ventral hernia by Dr Teo
Ventral hernia by Dr TeoVentral hernia by Dr Teo
Ventral hernia by Dr Teo
 
Testicular torsion by Dr Teo
Testicular torsion by Dr TeoTesticular torsion by Dr Teo
Testicular torsion by Dr Teo
 
Uk malaria treatment guideline
Uk malaria treatment guidelineUk malaria treatment guideline
Uk malaria treatment guideline
 
Tuberculosis summary
Tuberculosis summaryTuberculosis summary
Tuberculosis summary
 
Shock summary
Shock summaryShock summary
Shock summary
 

Dernier

PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 

Dernier (20)

PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 

Bohomolets Microbiology Lesson #4

  • 1. Lesson N4: LABORATORY DIAGNOSIS OF ESCHERICHIOSIS 1.Scientifically methodical ground of theme Strains of Escherichia coli and related Gram-negative bacteria predominate among the aerobic commensal flora present in the gut of man and animals. Individuals have a rich flora in the lower ileum and, more specially, in the colon, which includes Escherichia coli. It is acquired by ingestion of the organisms during the first few days after birth. The species Escherichia coli contains a great variety of strains that include purely commensal organisms as well as those possesing combinations of virulance determinants that enable them to act as spesific pathogens of the gut and extraintestinal sites, especially the urinary tract. 2.Educational purpose Students must know: 1. Structure, staining properties ànd cultivation E. coli. 2. Antigenic structure of E. coli, their classification. 3. Fermentative properties and toxin production of E. coli 4. Main clinical forms of escherichiosis. 5. Methods of laboratory diagnosis of diseases, main methods of prophylaxis and treatment. Students should be able to: – prepare the smears from pure culture; – stain the smears by Gram’s technique; – make microscopical examination of the smears; - carry out agglutination test for determination of serovar of E. coli. 3.Chart of topic content. Escherichia coli. The organism was isolated from faeces in 1885 by T. Escherich.E.coli is a common inhabitant of the large intestine of humans and mammals. It is also found in the guts of birds, reptiles, amphibians, and insects. The bacteria are excreted in great numbers with the faeces and are always present in the external environment (soil, water, foodstuffs, and other objects). Morphology. E coli are straight rods measuring 0.4-0.7 in breadth and 1-3 in length. They occur as individual organisms or in pairs and are marked by polymorphism. There are motile and non-motile.The cell surface has pili on which certain phages are adsorbed. The microcapsule is not always clearly defined. Cultivation. E. coli is a facultative anaerobe. The optimum temperature for growth is 30-37 °C and the optimum pH value of medium up 7.2-7.5. The organism also grows readily on ordinary media at room temperature and at 10 and 45 °C, growth becomes visible in the first two days. E. coli from cold-blooded animals grows at 22-37° C but not at 42-43° C. On meat-peptone agar E. coli produces slightly convex semitransparent, greyish colonies, and in meat broth it forms diffuse turbidity and a precipitate. The organism produces colonies which are red on Ploskirev's medium, red with a metallic hue on Endo's medium, and dark-blue on Levin's medium. Fermentative properties.Glucose, lactose, mannitol, maltose and many other sugers are fermented with production of acid and gas. Tipical strains do not fermant sucrose. Gelatin is not liquified, H2S is not formed, irea is not split and growth does not occur in KCN medium. Virulence factors. Certain strains of E. coli are conditionally pathogenic. They contain a gluco-lipo-protein complex with which their toxic, antigenic, and immunogenic properties are associated. Some strains possess haemolytic properties (O124 and others) determined by plasmids. Pathogenic cultures possess endotoxins and thermolabile neurotropic exotoxins. The latter accumulate in broth cultures on the second-fourth day of cultivation, while the endotoxins appear only after the twentieth day. Haemotoxins and pyrogenic substances, proteinases, deoxyribonucleases, urease, phosphatase, hyaluronidase, amino acid decarboxylases have been obtained from pathogenic strains. Antigenic structure. The antigenic structure of E. coli is characterized by variability and marked individuality. Along with the H- and O-antigens, the presence of other antigens has been shown m some strains, i.e. the surface somatic (membranous, capsular) K-antigens which contain the thermolabile L- and B-antigens and the thermostable A- and M-antigens. Each antigen group in its turn is composed of a number of antigens designated by Arabic numbers, e.g. the O-group has 173 antigens, the K-subgroup 90, the H-subgroup 50, etc. On the basis of antigenic structure an antigenic formula is derived which fully reflects the antigenic properties of the strain.For example, one of the most 1
  • 2. widely spread serotypes is designated 0111 : K58 : H2. Under the effect of transformation, lysogenic conversion, transduction, and conjugation E. coli may change its antigenic properties. Numerous varieties of the organism are produced on cultivation under artificial conditions. Such varieties are not only of theoretical interest, but also of great practical importance in laboratory diagnosis of enteric infections. Classification. The genus Escherichia includes E. coli, E. freundi, E. intermedia, and others. E. coli species consisting of several biotypes and serotypes. They are differentiated according to cultural, biochemical, and serological properties F. Kauffmann has detected 25 O-groups responsible for various diseases in humans. About 50 phage variants have been revealed among E. coli organisms. They are used in laboratory diagnosis as confirmatory characteristics of the isolated serotypes. Resistance. E. coli survives in the external environment for months. It is more resistant to physical and chemical factors of the external environment than the typhoid and dysentery bacteria. E. coli is killed comparatively rapidly by all methods and preparations used for disinfection. At 55° C the organism perishes in 1 hour, and at 60° C in 15 minutes. E. coli is sensitive to brilliant green. E. coli is used as a test microbe in the assay of disinfectants and methods of disinfection and also in titration of certain antibiotics. Pathogenesis and diseases in man. Definite E. coli serogroups are capable of causing various acute intestinal diseases in humans: (1) the causative agents of colienteritis in children are O-groups-25, -26, -44, -55, -86, -91, -111, -114, -119, -125, -126, -127, -128, -141, -146, and others (they cause diseases in infants of the first months of life and in older infants); (2) the causative agents of dysentery-like diseases are E. coli of the O- groups-23, -32, -115, -124, -136, -143, -144, -151, and others; (3) the causative agents of cholera-like diarrhoea are the O-groups-6, -15, -78, -148, and others, they produce thermolabile and thermoresistant enterotoxins. Colienteritis begins acutely with high temperature (38-39 °C), and frequently with severe meteorism, vomiting, diarrhoea, and general toxicosis. The disease usually occurs in infants of the first year of life. The infection is acquired from sick children or carriers. Pathogenic E. coli serovars are found on various objects. It is assumed that colienteritis is transmitted not only by the normal route for enteric infections but also through the respiratory tract by the droplets and dust. The pathogenesis of colienteritis depends entirely on the organism's condition. In prematurely born infants and in infants during the first months of life the bactericidal activity of blood is considerably lower in respect to the pathogenic E. coli serovars in comparison to the nonpathogenic types. The reactivity of the child's body at the time of infection plays an important role in the mechanism of resistance to the pathogenic strains. The pathological process develops mainly in the small intestine. Most probably, the mucous membrane of the small intestine in particular is exposed to the action of thermolabile toxic substances. Serovars O-124, O-151 and others cause diseases which are similar to dysentery. E. coli may cause colibacillosis in adults (peritonitis, meningitis, enteritis, toxinfections, cystitis, pyelitis, pyelonephntis, angiocholitis, salpingooophontis, appendicitis, otitis, puerperal sepsis, etc.). Overstrain, exhaustion, and conditions following infectious diseases facilitate the onset of various E. coli infections. In a number of cases the organism is responsible for food poisoning. Immunity. In individuals who had suffered from diseases caused by pathogenic E. coli serovars, cross immunity is not produced owing to which reinfection may occur. Over 85 per cent of E. coli strains contain inhibiting substances, colicins, marked by antagonistic properties in relation to pathogenic microbes of the enteric group, they are used as therapeutic and preventive agents, e.g. colibacterin (E. coli M 17, etc.). Besides this, E coli as well as other common inhabitants of the intestine are capable of synthesizing various vitamins (K2, E, and group B) which are indispensable to the human organism. The ability of various E. coli serovars to suppress the growth of Mycobacterium tuberculosis has also been observed. The suppression of E. coli and other members of the biocoenosis may result in a chronic disease known as dysbacteriosis. Laboratory diagnosis. The patients' faeces, throat and nasal discharges, material obtained at autopsy (blood, bile, liver, spleen, lungs, contents of the small and large intestine, pus), water, foodstuffs, and samples of washings from objects and hands of staff of maternity hospitals, hospitals, and dairy kitchens are all used for laboratory examination during colienteritis. If possible, faecal material should be inoculated immediately after it has been collected. The throat and nasal discharges are collected with a sterile swab. Specimens of organs obtained at autopsy are placed in separate sterile jars. The tested material is inoculated onto solid nutrient media (Endo's, Levin's) and, simultaneously, onto Ploskirev's media and bismuth-sulphite agar for isolation of bacteria of the typhoid-paratyphoid and dysentery group.Blood is first inoculated into broth and then subcultured on solid media when development of a septic process is suspected. Pus is collected for examination in suppurative lesions. It is placed into a dry sterile vessel and then inoculated onto the differential media of Endo or Levin. The pure culture isolate is identified by its morphological, cultural, biochemical, serological, and biological properties. 2
  • 3. The corresponding 0-group to which an enteropathogenic-serovars belong is determined by means of the agglutination reaction after the K-antigen of the culture that is being studied has been destroyed by boiling. Besides, the immunofluorescence method employing type specific labelled sera is also used. It yields a preliminary answer in one to two hours. In serological diagnosis of colienteritis beginning with the third to fifth day of the disease the indirect haemagglutination reaction is used which excels the agglutination reaction in sensitivity. It is positive when the antibody titre grows in the course of the diseased. Treatment. Patients with colienteritis are prescribed antibiotics (tetracycline with vitamins C, B 1 and B2) and biopreparations (coli autovaccine, coli bacteriophage, colicin, bacterin, lactobacterin, bificol, bifidumbacterin). Physiological solutions with glucose are injected for controlling toxicosis. Prophylaxis. To prevent diseases caused by pathogenic serovars of E. coli, special attention is given to early identification of individuals suffering from colienteritis, and also to their hospitalization and effective treatment. Regular examination of personnel is necessary in children's institutions as well as of mothers whose children are suffering from dyspepsia. Considerable importance is assigned to observation of sanitary regulations in children's institutions, infant-feeding centres, maternity hospitals, and nurseries. Protection of water and foodstuff's from contamination with faeces, the control of flies, and gradual improvement of standards of hygiene of the population are also particularly important. Sanitary significance of E. coli. This organism is widely spread in nature. It occurs in soil, water, foodstuff's, and on various objects. For this reason E. coli serves as an indicator of faecal contamination of the external environment. Detection of E. coli is of great importance in estimating the sanitary index of faecal contamination of water, foodstuff's, soil, beverages, objects, and hand-washings. The degree of contamination of water, soil and foodstuff's is determined by the coli titre or coli index.Faecal contamination of articles of use is estimated by qualitative determination of the presence of E. coli. Pathogenicity of Escherichia coli. Although E. coli is part of the normal flora of the intestinal tract, it is also the most common gram-negative pathogen responsible for nosocomially acquired septic shock, meningitis in neonates, cystitis and pyelonephritis in women, and for several distinct forms of diarrheal disease and dysentery affecting populations throughout the world. Strains of E coli capable of causing such diseases possess one or more virulence factors that are not found in E. coli strains comprising the normal flora. Such virulence factors can be characterized as follows, the capacity to adhere to specific mammalian cells; the ability to invade and grow intracellularly in intestinal epithelial cells; the secretion of one or more enterotoxins that cause fluid loss, resulting diarrhea; the formation of a cytotoxin that blocks protein synthesis, causing a hemorrhagic colitis; and the possession of an antiphagocytic capsule that is responsible, at least in part, for the bacteremia and meningitis caused by E. coli. In addition, the ability to obtain iron from transferrin or lactoferrin by the synthesis of iron- binding siderophores markedly enhances the virulence of such strains through their ability to grow in host tissues. No one strain of E. coli possesses all of these properties but all pathogenic strains must have one or more virulence factors to produce disease. Diarrheal Diseases. Diarrhea kills more people worldwide than AIDS and cancer, with about five million diarrheal deaths occurring annually primarily because of dehydration. Most of these occur in neonates and young children, anda large number are caused by pathogenic E. coli. The disease in adults, known by many names such as traveller’s diarrhea or Montezuma's revenge, may vary from a milddisease with several days of loose stools to a severe and fatal cholera-like disease. Such life-threatening E. coli infections occur throughout the world but are most common in developing nations. The virulence factors responsible for diarrheal diseaseare frequently encoded in plasmids, which may be spread from one strain to another either through transduction : or by recombination. As a result, various combinations of virulence factors have occurred, which has been used to place the diarrhea-producing strains of E. coli into various groups based on the mechanism of disease production Enterotoxigenic Escherichia coli. Enterotoxin-producing E coli, called enterotoxigenic E.coli (ETEC), produce one or both of two different toxins – a heat labile toxin called LT and a heat-stable toxin called ST. The genetic ability to produce both LT and ST is controlled by DNA residing in transmissible plasmids called ent plasmids. Both genes have been cloned, and the ST gene has been shown to possess the characteristics of a transposon. HEAT-LABILE TOXIN. The heat-labile toxin LT, which is destroyed by heating at 65 °C for 30 minutes, has been extensively purified, and its mode of action is identical to that described for cholera toxin (CT). LT has a molecula weight of about 86,000 daltons and is composed of two subunits, A and B Subunit A consists of one moleculeof Ai (24,000 daltons) and one molecule of A2 (5000daltons) linked by a disulfide bridge. Each A unit is joined noncovalently to five B subunits. 3
  • 4. Like CT, LT causes diarrhea by stimulating the activity of a membrane-bound adenylate cyclase.This results in the conversion of ATP to cyclic AMP (cAMP). cAMP induce the active secretion of Cl– and inhibit the absorption of NaCI, creating an electrolyte imbalance across the intestinal mucosa, resulting in the loss of copious quantities of fluid and elec-trolytes from the intestine. The mechanism by which LT stimulates the activity of the adenylate cyclase is as follows: (1) The B subunit of the toxin binds to a specific cell receptor, GM1 ganglioside, (2) the A1 subunit is released from the toxin and enters the cell; and (3) the A1 subunit cleaves nicotinamide-adenic dinucleonde (NAD) into nicotinamide and ADP- ribose and, together with a cellular ADP-ribosylating factor, transfers the ADP-ribose to aGTP-binding protein. The ADP-ribosylation of the GTP-binding protein inhibits a GTPase activity of the binding protein, leading to increased stability of the catalytic cornplex responsible for adenylate cyclase activity. This results in an amplified activity of the cyclase and a corresponding increase in the amount of cAMP produced. Two antigenically distinct heat labile toxins are produced by various strains of E. coli. LT-I is structurally andantigenically related to CT to an extent that anti-CT will neutralize LT I LT-II has, on rare occasions, been isolated from the feces of humans with diarrhea, but it is most frequently isolated from feces of water buftalos and cows LT-II is biologically similar to LT-I, but it is notneutralized by either anti-LT-I or anti-CT. LT will bind to many types of mammalian cells, and its ability to stimulate adenylate cyclase can be assayed incell cultures. A report has also shown that CT stimulated an increase in prostaglandin E (PGE), and that PGE1 and PGE2 caused a marked fluid accumulation in the ligated lumen of rabbit intestinal segments. The mechanism whereby CT induces PGE release is unknown. HEAT-STABLE TOXIN The heat-stable toxin STa consists of a family of small, heterogeneous polypeptides of 1500 to 2000 daltons that are not destroyed by heating at 100 °Cfor 30 minutes. STa has no effect on the concentration of cAMP, but it does cause a marked increase the cellular levels of cyclic GMP (cGMP). cGMP causes an inhibition of the cotransport of NaCI across the intestinal wall, suggesting that the action of STa may be primarily antiabsorptive compared with that of LT, which is both antiabsorptive and secretory. STa stimulates guanylate cyclase only in intestinal cells, indicating that such cells possess a unique receptorfor Sta. The cell receptor for STa is known to be either tightly coupled to, or a part of, a particulate form of guanylate cyclase located in the brush border membranes of intestinal mucosal cells. Also, intimately associated with this complex is a cGMP-dependent protein kinase that phosphorylates a 25,000 dalton protein in the brush border. It has been proposed that this phosphorylated protein might be the actual mediator for the toxin-induced iontransport alterations that lead to fluid loss. The usual assay for STa is to inject the toxin intragastrically into a 1 – to 4-day old suckling mouse and measure intestinal fluid accumulation (as a ratio of intestinal/remaining body weight) after 4 hours. STa may also be assayed directly by measuring its effect on the increase in guanylate cyclasein homogenized intestinal epithelial cells. A second heat stable toxin that is produced by somestrains of E. coli has been termed STb. This toxin is inactivein suckling mice but will produce diarrhea in weaned piglets. STb producers have not been isolated from humans. It does not seem to increase the level of adenylate or guanylate cyclase in intestinal mucosal cells, but maystimulate the synthesis of prostaglandin E2. The end resuit is to enhance net bicarbonate ion secretion. COLONIZATION FACTORS. Animals also are subjects to infections by their own strains of ETEC, and such infections in newborn animals may result in death from the loss of fluids and electrolytes. Extensive studies of strains infecting newborn calves and piglets (as well as humans) have revealed that, in addition to producing an enterotoxin, such strains possess one of several fimbriate surface structures that specifically adhere to the epithelial cellslining the small intestine. These antigens (K-88 for swine strains, and K-99 for cattle) usually are fimbriate structures that cause the toxin-producing organisms to adhere to and colonize the small intestine. The need for this colonizing ability is supported by the fact that antibodies directed against the colonizing fimbriae are protective. Analogous human ETEC strains also possess fimbriate structures that have been designated as colonizationfactors (CFA). At least five such serologicallydifferent factors, CFA/I, CFA/II, CFA/III, E8775, andCFA/V, have been described. Interestingly, these colonization factors also are plasmid mediated, and single plasmids have been described that carry genes for both CFA/I and STa. Enterohemorrhagic Escherichia coli. The enterohemorrhagic E. coli (EHEC) were first described in 1982 when they were shown to be the etiologic agent of hemorrhagic colitis, a disease characterized by severe abdominal cramps and a copious, bloody diarrhea. These organisms are also known to cause a condition termed hemolytic- uremic syndrome (HUS), which is manifested by a hemolytic anemia, thrombocytopenia (decrease in the number of blood platelets), and acuterenal failure. HUS occurs most frequently in children. Although most initially recognized EHEC belong to serotype O157:H7, other EHEC serotypes such as O26, O111, O128, and O143 have been recognized. These organisms are not invasive, but they do possess a 60- megadalton plasmid that encodes for a fimbrial antigen that adheres to intestinal epithelium. In addition, the EHEC 4
  • 5. are lysogenic for one or more bacteriophages that encode for the production of one or both of two antigenically distinct toxins. These toxins are biologically identical and antigenically similar to the toxins formed by Shigella dysenteriae (Shiga's bacillus), and are designated as Shiga-like toxin I (SLT-I) and Shiga-like toxin II (SLT II). Because the Shiga-like toxins initially were characterized by their ability to kill Vero cells, a cell line developed from African green monkey kidney cells, they also arecalled Verotoxin I and Verotoxin II. SLT I consists of an A subunit and five B subunits. The sequence of the B subunit from S. dysenteriae type 1 is identical to that of the B subunit of SLT I. The B subunit binds specifically to a glycolipid in microvillus membranes, and the released A subunit stops protein synthesis by inactivating the 60S ribosomal subunit. This inactivation results from the N-glycosidase activity of the toxin, which cleaves off an adenine molecule (A-4324) from the 28S ribosomal RNA, causing a structural modification of the 60S subunit, resulting in a reduced affinity for EF-1 and, thus, an inhibition of aminoacyl- tRNA binding. The consequence of toxin action is a cessation of protein synthesis, the sloughing off of dead cells, anda bloody diarrhea. Notice that SLT 1 carries out the same reaction as the plant toxins ricin and abrin. SLT II is biologically similar to SLT I, but because only a 50% to 60% homology exists between the two toxins, it is not surprising that they are antigenically distinct. Interestingly, both STL I and STL-II can be transferred to nontoxin producing strains of E. coli by transduction. Outbreaks of hemorrhagic colitis have been traced to contaminated food as well as to person to person transmission in nursing homes and day care centres. Contaminated, undercooked hamburger meat seems to be the most frequently implicated source of food borne illnesses followed by contaminated milk and water, indicating thatcattle are a common reservoir for EHEC. Of note is that E. coli 0157:H7 has been shown to survive up to 9 months at -20°C in ground beef. Thus, the EHEC are able to cause hemorrhagic colitis as a result of their ability to adhere to the intestinal mucosa, and they presumably destroy the intestinal epithelial lining through their secretion of Shiga like toxins. The mechanism whereby the EHEC cause HUS is unclear but seems to follow bloodstream carriage of SLT II to the kidney. Experimental results have shown that humanrenal endothelial cells contain high levels of receptor for SLT-2. Moreover, in the presence of interleukin (IL)1/β, the amount of receptor increases, enhancing the internalization of the toxin and the death of the cell. The section, "A Closer Look," describes several epidemics of hemorrhagic colitis that have occurred in the United States and techniques that are used for the identification of this serotype Enteroinvasive Escherichia coli The disease produced by the enteroinvasive E. coli (EIEC) is indistinguishable from the dysentery produced by members of the genus Shigella, although the shigellae seem to be more virulent.The key virulence factor required by the EIEC is the ability to invade the epithelial cells. EIEC INVASION. The specific property that provides these organisms with their invasive potential is far from understood. It is known, however, that this ability is encoded in a plasmid and that the loss of the plasmid results in a loss of invasive ability and a loss of virulence. Moreover, the shigellae seem to possess the same plasmid, because Western blots show that shigellae and EIEC plasmids express polypeptides that are similar in molecular weight and antigenicity. Enteropathogenic Escherichia coli. The enteropathogenic E. coli (EPEC) are diffusely adherent organisms that are particularly important in infant diarrhea occurring in developing countries, where they may cause a mortality rate as high as a 50%. They comprise a mixture of organisms that seem to produce diarrhea by a two-step process. The classic EPEC exist among a dozen or so different serotypes, all of which are characterized by the possession of a 55 to 65-megadalton plasmid that encodes for an adhesin termed EPEC adherence factor (EAF). EAF causes a localized adherence of the bacteria to enterocytes of the small bowel, resulting in distinct microcolonies. This is followed by the formation of unique pedestal-like structures bearing the adherent bacteria. These structures have been termed attaching and effacing lesions. The ability to form the effacing lesion resides in an attaching and effacing gene (eae). The lesions are characterized by a loss of microvilli and a rearrangement of the cytoskeleton, with a proliferation of filamentous actin beneath are as of bacterial attachment. Thus, the ability of the EPEC to cause diarrhea involves two distinct genes, EAF and eae. The end result is anelevated intracellular Ca+2 level in the intestinal epithelialcells and the initiation of signal transduction, leading to protein tyrosine phosphorylation of at least two eucaryotic proteins. EPEC strains routinely have been considered noninvasive, but data have indicated that such strains can invadeepithelial cells in culture. However, EPEC strains do not typically cause a bloody diarrhea, and the significance of cell invasion during infection remains uncertain. Other Diairhea-Producing Escherichia coli. All possible combinations, deletions, or additions of the various virulence factors responsible for intestinal fluid loss result in diarrhea producing strains that do not fit the categories already described. Such has been found tobe the case. 5
  • 6. The most recent of these has been termed the enteroaggregative E. coli. These strains seem to cause diarrhea through their ability to adhere to the intestinal mucosa and possibly by yet a new type of enterotoxin. It seems possible that the acquisition of other virulence factors may result in the discovery of additional pathogenic strains of E. coli. E. coli Urinary Tract Infections. Escherichia coli is the most common cause of urinary tract infections of the bladder (cystitis) and, less frequently, of the kidney (pyelonephritis). In either case, infections usually are of an ascending type (enter the bladder from the urethra and enter the kidneys from the bladder). Many infections occur in young female patients, in persons with urinary tract obstructions, and in persons requiring urinary catheters, and they occur frequently in otherwise healthy women. Interestingly, good data support the postulation that certain serotypes of E. coli are more likely to cause pyelonephritis than others. Thus, the ability to produce P-fimbriae (so called because of their ability to bind to P blood group antigen) has been correlated with the ability to produce urinary tract infections, seemingly by mediating the adherence of the organisms to human uroepithelial cells. Of note is that the rate of nosocomial urinary tract infection per person-day was significantly greater in patients with diarrhea, particularly in those with an indwelling urinary catheter. In addition to fimbrial adhesins, a series of afimbrial adhesins has been reported. Their role in disease is not yet firmly established, but it has been demonstrated that at least one afimbrial adhesins mediated specific binding to uroepithelial cells. Recurrent urinary tract infections in premenopausal, sexually active women frequently can be prevented by the postcoital administration of a single tablet of an antibacterial agent such as trimethoprim-sulfamethoxazole, cinoxacin, or cephalexin. E. coli Systemic Infections. About 300,000 patients in United States hospitals develop gram-negative bacteremia annually, and about 100,000 of these persons the of septic shock. As might be guessed, E. coli is the most common organism involved in such infections. The ultimate cause of death in these cases is an endotoxin- induced synthesis and release of tumor necrosis factor-alpha and IL-1, resulting in irreversible shock. The newborn is particularly susceptible to meningitis, especially during the first month of life. A survey of 132 cases of neonatal meningitis occurring in the Netherlands reported that 47% resulted from E. coli and 24% from group B streptococci. Notice that almost 90% of all cases of E. coli meningitis are caused by the K1 strain, which possesses a capsule identical to that occurring on group B meningococci. Table 1: Escherichia coli Virulence Factors Diarrhea-producing Virulence Factors E. coli Enteroroxigenic E. coli Heat-labile toxin (LT) Heat-stable toxin (ST) Colonization factors (fimbriae) Enterohernorrhagic E. Shiga like toxin (SLT-I) coli Shiga like toxin II (SLF-II) Colonisation factors (fimbriae) Enteroinvasive E. coli Ability to invade epithelial cells Shiga like toxin (SLT-I)? Shiga like toxin II (SLF-II)? Enteropathogenic E. Adhesin factor for epithelial cells coli Urinary trace P- fimbriae infections Meningitis K-1 capsule 4. Student’s independent study program 1. General characteristics of Enterobacteriaceae. 2. Structure and tinctorial properties of Escherichia coli. Cultivation. 3. Biochemical properties of E. colі. 4. Peculiarities of antigenic structure of E. colі. Pathogenic serovars of E. coli. 5. Virulence factors of E. colі and their action on organism (pili, colicines, endotoxins, protein toxins). 6. Enteropathogenic, enteroinvasive, enterotoxigenic, enterohemorrhagic E. coli. Diseases they are caused. 6
  • 7. 7. Methods of diagnosis of colienterites and other diseases, which caused by E. coli. Peculiarities of getting of tested material for bacteriological examination and its main stages. Significance of serological identification of causative agents. 8. Prophylaxis of colienterites. 5. Students’ practical activities: 1. To prepare a smear from E. coli, to stain it by Gram’s method and to examine under microscope. 2. To examine the growth perculiarities of E. coli on MPA, Endo’s, Levin’s, Ploskirev’s media, in MPB. 3. To examine biochemical activity of E. coli on Hiss’ media. 4. To carry out presumptive agglutination test with typical sera and culture of an unknown serovar of E. coli. 5. To familiarize with specific diagnostic agglutination Sera. 6. To end diagnostic of inflammatory process causing by staphilococci. Evaluate sensitivity of isolated strain to antibiotics. 6. Control questions and tests Select the correct answers. 1. E. coli has such properties: A – peritrichate; B – Gram-negative; C –does not have flagella; D – gram-positive; E – forms spores. 2. A – grows on Endo’s and Levin’s media; b – on media with lactose the colonies are colour; c – on media with lactose the colonies are colourless; e – does not grow without presence of native protein. 3. A – ferments all carbohydrates of Hiss’ media with production of an acid and gas; b – does not ferment a saccharose; c – produces indole; d – produces hydrogen sulfide; e – fermentats all carbohydrates of Hiss’media with the exception of a saccharose. 3. What antigen do determine serological groups of Escherichia; in what immunological reaction it can be determined? A – K, precipitation test; b – Н, agglutination test; c – O, agglutination test; d – K and Н, agglutination test; e – O, flocculation test. 5. Characteristic of pathogenic serovars: a – enteropathogenic E. coli produce enterotoxins with adenylate cyclase activity; b – enteroinvasive Escherichia coli cause dysentery-like diseases; c – enterotoxigenic Escherichia coli are not capable to parasitize in the cells; d – enterotoxigenic Escherichia coli cause dysentery-like diseases; e – enterotoxigenic Escherichia coli secrete a toxin with adenylate cyclase activity. 6. One can differentiate commensal E. coli from enteropathogenic E. coli using: a – biochemical properties; b –endotoxin production; c – antigenic structure; d –pathogenicity for animals; e – resistance to antibiotics 7. List of literature: 1.S. Gaidash, V.V. Flegontova, Microbiology, virology and immunology, Lugansk, 2004,part 2, chapter24, p. 171-182. I 7